Finance committee  Most of the large-scale projects are of an order of three to four years. That's from science through to application--so application in terms of, for example, a lung cancer project or something like that. Some of the projects are ongoing, with a life of about a year and a half be

Finance committee  I think the issue, John, is really the fact that there needs to be some signal, one way or another, of the plan of the government to invest in science and technology generally, and that plan needs to be well understood. Any particular government needs to be able to send that part

Finance committee  I think there's a number of ways, actually, to measure that. You can measure it at a scientific level, and then you can measure it really at an industry level. On the scientific side, Canada ranks around sixth or seventh in the world in the area of generating genomics or proteom

Finance committee  --which is, I think, good progress. The next stage, though--that is, in science and technology, if you like, generating the information--is critical. The issue, to some extent, is then making sure this information translates both for social good, in terms of how we change the hea

Finance committee  Abstain.

Finance committee  I can speak for Genome B.C., which is an organization independent of Genome Canada. We compete for Genome Canada funds; they would fund 50% of anything we do. In the last provincial round Genome B.C. received money, but in the last federal round Genome Canada did not.

Finance committee  Yes, I do believe it is certainly an urgent issue. Part of the reason is that we have national momentum in this area, and it's fuelling to some extent some of the interest in attracting very good people and companies into British Columbia and other parts of Canada, so the answer

Finance committee  Thank you, Mr. Chairman, distinguished members of the finance committee, and my colleagues. First of all, thanks for travelling to Vancouver. I want to address the question you asked--Canada's place in a competitive world--in three ways: first, around life sciences; second, aro